©2012 DevicePharm Inc. All rights reserved.
The Experience to Know. The Resources to Do., From Opportunity to Success, DevicePharm, and the DevicePharm logo are registered trademarks of DevicePharm Inc.
$6 billion + $12 billion = Big changes in healthcare delivery Information Week reported that the telehealth market will hit $6.28 billion by 2020. In addition, presentations at a recent investor conference projected that the point-of-care molecular diagnostics market would reach $12 billion in revenue by 2017, which is fueled by cost-effective ...continue reading
![]()
It’s 11 pm on a Tuesday. A surgeon is at home reading a medical journal, and she’s intrigued by your ad for a new implantable device. During her only free time of the day, she goes to the website featured in your advertisement. Now what? At this moment, marketing shifts from ...continue reading
![]()
This is an update to my previous June 1st blog entry. Adobe has made huge improvements to Flash and its mobile publishing capabilities. For those who think that Flash is on its way out, I have some bad news: not only is it still in the fight for mobile development, it's now ...continue reading
![]()
A few years ago, equipping your medical sales team was easy. Well, not easy, but not as complex as it is now. You made some brochures, built some web properties, created laptop content—and you were ready to roll. Then, the iPad came along. J.P. Morgan estimates that Apple will have ...continue reading
![]()
At DevicePharm, we help our clients strategize, develop, and distribute mobile applications for their medical marketing needs. These applications are often positioned for different audience groups depending on their purpose. So the question often is: Which distribution model is right for my mobile app? The answer depends on a number of ...continue reading
![]()
![]()
©2012 DevicePharm Inc. All rights reserved.
The Experience to Know. The Resources to Do., From Opportunity to Success, DevicePharm, and the DevicePharm logo are registered trademarks of DevicePharm Inc.